Compare ARK Genomic Revolution ETF (ARKG) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs NetEase Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while NetEase Inc trades at $123.19 (market cap $82.75B). The key difference: NetEase Inc pays a 2.36% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, NetEase Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | NTES | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $44.55 | $159.34 |
52-Week Low | $24.02 | $109.26 |
Market Cap | — | $82.75B |
Enterprise Value | — | $59.05B |
Dividend Yield | — | 2.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
